GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » EV-to-EBIT

Paul Hartmann AG (FRA:PHH2) EV-to-EBIT : 12.91 (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Paul Hartmann AG's Enterprise Value is €837 Mil. Paul Hartmann AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65 Mil. Therefore, Paul Hartmann AG's EV-to-EBIT for today is 12.91.

The historical rank and industry rank for Paul Hartmann AG's EV-to-EBIT or its related term are showing as below:

FRA:PHH2' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.13   Med: 10.32   Max: 15.44
Current: 12.91

During the past 13 years, the highest EV-to-EBIT of Paul Hartmann AG was 15.44. The lowest was 5.13. And the median was 10.32.

FRA:PHH2's EV-to-EBIT is ranked better than
66.74% of 463 companies
in the Medical Devices & Instruments industry
Industry Median: 19.98 vs FRA:PHH2: 12.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Paul Hartmann AG's Enterprise Value for the quarter that ended in Dec. 2023 was €882 Mil. Paul Hartmann AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65 Mil. Paul Hartmann AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.35%.


Paul Hartmann AG EV-to-EBIT Historical Data

The historical data trend for Paul Hartmann AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paul Hartmann AG EV-to-EBIT Chart

Paul Hartmann AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.60 6.85 8.44 14.19 13.61

Paul Hartmann AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.44 - 14.19 - 13.61

Competitive Comparison of Paul Hartmann AG's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paul Hartmann AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Paul Hartmann AG's EV-to-EBIT falls into.



Paul Hartmann AG EV-to-EBIT Calculation

Paul Hartmann AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=836.939/64.808
=12.91

Paul Hartmann AG's current Enterprise Value is €837 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paul Hartmann AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paul Hartmann AG  (FRA:PHH2) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Paul Hartmann AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=64.808/881.98544
=7.35 %

Paul Hartmann AG's Enterprise Value for the quarter that ended in Dec. 2023 was €882 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paul Hartmann AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paul Hartmann AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Paul Hartmann AG (FRA:PHH2) Business Description

Traded in Other Exchanges
Address
Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Executives
Eduard Schleicher Supervisory Board
Britta Fünfstück Board of Directors

Paul Hartmann AG (FRA:PHH2) Headlines

No Headlines